First Nebraska Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $530K | Sell |
3,802
-55
| -1% | -$7.7K | 0.05% | 136 |
|
|
2025
Q4 | $473K | Hold |
3,857
| – | – | 0.04% | 140 |
|
|
2025
Q3 | $428K | Hold |
3,857
| – | – | 0.04% | 137 |
|
|
2025
Q2 | $428K | Hold |
3,857
| – | – | 0.04% | 136 |
|
|
2025
Q1 | $432K | Hold |
3,857
| – | – | 0.04% | 131 |
|
|
2024
Q4 | $356K | Hold |
3,857
| – | – | 0.03% | 147 |
|
|
2024
Q3 | $323K | Sell |
3,857
-90
| -2% | -$6.87K | 0.03% | 157 |
|
|
2024
Q2 | $271K | Hold |
3,947
| – | – | 0.03% | 164 |
|
|
2024
Q1 | $289K | Sell |
3,947
-40
| -1% | -$3.08K | 0.03% | 154 |
|
|
2023
Q4 | $323K | Hold |
3,987
| – | – | 0.04% | 143 |
|
|
2023
Q3 | $299K | Hold |
3,987
| – | – | 0.04% | 140 |
|
|
2023
Q2 | $307K | Hold |
3,987
| – | – | 0.04% | 137 |
|
|
2023
Q1 | $331K | Hold |
3,987
| – | – | 0.04% | 130 |
|
|
2022
Q4 | $342K | Hold |
3,987
| – | – | 0.04% | 130 |
|
|
2022
Q3 | $246K | Hold |
3,987
| – | – | 0.04% | 140 |
|
|
2022
Q2 | $246K | Hold |
3,987
| – | – | 0.03% | 144 |
|
|
2022
Q1 | $237K | Hold |
3,987
| – | – | 0.03% | 158 |
|
|
2021
Q4 | $289K | Sell |
3,987
-801
| -17% | -$55.2K | 0.03% | 147 |
|
|
2021
Q3 | $334K | Hold |
4,788
| – | – | 0.04% | 128 |
|
|
2021
Q2 | $330K | Hold |
4,788
| – | – | 0.04% | 128 |
|
|
2021
Q1 | $309K | Hold |
4,788
| – | – | 0.04% | 133 |
|
|
2020
Q4 | $279K | Sell |
4,788
-140
| -3% | -$8.45K | 0.04% | 135 |
|
|
2020
Q3 | $311K | Sell |
4,928
-16
| -0.3% | -$1.11K | 0.05% | 120 |
|
|
2020
Q2 | $380K | Hold |
4,944
| – | – | 0.07% | 109 |
|
|
2020
Q1 | $370K | Hold |
4,944
| – | – | 0.08% | 105 |
|
|
2019
Q4 | $321K | Hold |
4,944
| – | – | 0.05% | 116 |
|
|
2019
Q3 | $313K | Buy |
4,944
+700
| +16% | +$45.8K | 0.05% | 119 |
|
|
2019
Q2 | $287K | Hold |
4,244
| – | – | 0.05% | 116 |
|
|
2019
Q1 | $276K | Hold |
4,244
| – | – | 0.05% | 117 |
|
|
2018
Q4 | $265K | Sell |
4,244
-38
| -0.9% | -$2.66K | 0.05% | 111 |
|
|
2018
Q3 | $331K | Hold |
4,282
| – | – | 0.06% | 106 |
|
|
2018
Q2 | $303K | Hold |
4,282
| – | – | 0.07% | 109 |
|
|
2018
Q1 | $323K | Hold |
4,282
| – | – | 0.06% | 103 |
|
|
2017
Q4 | $307K | Buy |
4,282
+2
| +0% | +$152 | 0.06% | 106 |
|
|
2017
Q3 | $347K | Hold |
4,280
| – | – | 0.08% | 100 |
|
|
2017
Q2 | $303K | Buy |
4,280
+920
| +27% | +$61.2K | 0.07% | 108 |
|
|
2017
Q1 | $228K | Buy |
+3,360
| New | +$236K | 0.05% | 117 |
|
Other funds holding GILD
VCM
VPM
First Nebraska Trust's GILD Position: Q1 2026 in Review
First Nebraska Trust reduced its Gilead Sciences (GILD) stake by 1.4% in Q1 2026, selling an estimated $7.7K and leaving 3,802 shares worth $530K. The position accounts for 0.05% of the portfolio, ranked #136.
First Nebraska Trust first reported a position in GILD in Q1 2017 and has held it in 37 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- First Nebraska Trust held 3,802 shares of Gilead Sciences worth $530K as of Q1 2026.
- First Nebraska Trust sold 55 Gilead Sciences shares in Q1 2026, an estimated $7.7K.
- Gilead Sciences made up 0.05% of First Nebraska Trust's portfolio in Q1 2026, its #136 holding.
- First Nebraska Trust first reported a position in Gilead Sciences in Q1 2017 and has held it in 37 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.